Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Early-Stage Development of Informatics Technologies for…

U.S. National Institutes of Health·United States of America

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Closes 10/19/2027$50k – $300kGrants Notice
Get bids like this by emailBid source

Description

This Notice of Funding Opportunity (NOFO) solicits applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum. The central mission of the Informatics Technology for Cancer Research (ITCR) Program is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. Key aspects of this opportunity include: • Potential to advance driving cancer research projects and the cancer research field in general • Novel informatics capabilities for the targeted cancer research domain • Compelling plans and processes for engaging end users to evaluate and apply the tool or resource • A realistic timeline and milestones for technology development The emphasis will be on uniqueness and potential impact on cancer research.

Attached files

Contact

Juli Klemm(Program Official/Project Scientist)

[email protected]

(202) 853-7889

Key dates

Opened
7/2/2025
Closes
10/19/2027
Projected award
7/1/2026
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-CA-27-019

Budget estimate

$50,000 – $300,000

The estimated funding for this opportunity is $2,400,000, with an award ceiling of $300,000 and an award floor of $50,000. Considering the scope of the project, which involves the development of enabling informatics technologies for cancer research and management, the budget amount may vary depending on the specific requirements and complexity of the project. However, based on the provided estimates, a reasonable budget estimation could be between $50,000 and $300,000. Factors that may influence the likely payment range include the number of awards, the scope of work, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 89%

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

86% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024

U.S. National Institutes of Health·United States of America

85% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

85% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

84% match

Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/9/2023

U.S. National Institutes of Health·United States of America

83% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

83% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

83% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

83% match

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/21/2022

U.S. National Institutes of Health·United States of America

82% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

80% match

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 11/18/2024

U.S. National Institutes of Health·United States of America

80% match

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

80% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023

U.S. National Institutes of Health·United States of America

80% match

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

80% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. National Institutes of Health·United States of America

80% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

80% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

80% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closes 11/6/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

79% match

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

Closes 7/30/2027Opened 9/29/2026

U.S. National Institutes of Health·United States of America

79% match

Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)

Closes 1/31/2028Opened 11/9/2021

U.S. National Institutes of Health·United States of America

79% match

Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)

Closes 11/5/2029Opened 9/29/2025

U.S. National Institutes of Health·United States of America

79% match

Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)

Closes 2/26/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

79% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

79% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

79% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 9/25/2028Opened 11/26/2025